Posters
« Back
Immune suppression in the early stage of COVID 19 disease
EP37741
Poster Title: Immune suppression in the early stage of COVID 19 disease
Submitted on 05 Oct 2021
Author(s): Nan Zhang 1 , Siyuan Wang 1 ,Catherine CL Wong 1*,
Affiliations: Center for Precision Medicine Multi Omics Research, Peking University Health Science Center, Peking University, Beijing 100191, China.
Poster Views: 38
View poster »


Poster Information
Abstract: COVID-19, the disease caused by infection with the virus SARS CoV 2, has become a worldwide pandemic. As yet, we know very little about this new virus and its pathogenesis. At the beginning of the pandemic, research studies focused on the management and treatment of severe and critical patients. Statistics showed that the elderly, especially those with underlying conditions such as heart disease, lung disease, obesity and diabetes, have the most severe symptoms. As the virus has now spread globally, more information is available about younger infected people in their 30s to 50s. In a growing number of cases, symptoms were expected to improve, but suddenly got worse. Patients can develop acute respiratory distress syndrome (or even die suddenly in a short period of time. This sudden change implies a “two stage” pattern of disease progression, but the underlying mechanisms are unknown. In this work, we apply a mass spectrometry based, data independent acquisition (quantitative proteomic approach to analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases. We expect our results to provide hints of how the two stage pathogenesis occurs.Summary: In this work, we apply a mass spectrometry based, data independent acquisition (quantitative proteomic approach to analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases.References: (1) Immune suppression in the early stage of COVID-19 disease. Nat Commun 2020; 11(1):5859.Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Real-time search of Ubiquitin diGLY modified peptides and PaSER acquisition control on the timsTOF PRO
Christopher Adams1; Robin Park1; Nagarjuna Nagaraj4; Sven Brehmer4; Matt Willetts3; Elizabeth Gordon3; Barry M. Zee2; Hayley Peckham2; Kimberly Lee2; Tharan Srikumar3

Proteomic profiling of IDH mutant gliomas enables prediction of chromosomal copy number variations
Marius Felix 1 2 Dennis Friedel 1 2 Ashok Kumar Jayavelu 4 Uwe Warnken 3 Damian Stichel 1 2 Christel Herold Mende 5 Laura Heikaus 6 Andreas von Deimling 1 2 and David E Reuss 1 2

OpenTIMS TimsPy TimsR: Open Access to timsTOF Pro Raw Data
Mateusz K. Łącki1, Michał P.Startek2, Sven Brehmer3, Christina Bell3, Ute Distler1, Stefan Tenzer1

Novel bifunctional material coupled to PASEF enables sensitive extracellular vesicles phosphoproteomic analysis of urine
Jie Sun1,2, W.Andy Tao3, Xiaoxian Du4 and Xianming Liu4

Implementation of Holistic Glycopeptide PASEF-DDA Data In Diagnostics
Hans JCT Wessels1, Purva Kulkarni1, Fokje Zijlstra1, Merel Post1, Melissa Bärenfänger1, Pierre-Olivier Schmit2, Alain J van Gool1, Dirk J Lefeber1